Medical Complications in Lung Transplant Recipients with Pulmonary Fibrosis

Lung transplantation is a therapeutic option for selected patients with severe interstitial disease who continue to have progressive clinical deterioration. There is a survival advantage for selected patients who undergo transplant, but it primarily improves quality of life after transplantation. Unfortunately, patients with IPF have worse outcomes following lung transplantation due to various factors. This review article will describe several common postoperative complications including an astamotic complications, allograft dysfunction, cardiovascular complications, thromboembolic phenomenon, renal failure, neurologic complications and complications related to the native lung in the single lung transplant recipients. *Corresponding author: Kamyar Afshar, Assistant Professor of Clinical Medicine, University of Southern California, Keck School of Medicine, Division of Pulmonary and Critical Care, 2020 Zonal Ave, IRD 723, Los Angeles, CA 90033, Tel: 323-226-7923; Fax: 323-226-2873; E-mail: [email protected] Received February 14, 2013; Accepted April 02, 2013; Published April 05, 2013 Citation: Afshar K, Orjioke N, Whelan T (2013) Medical Complications in Lung Transplant Recipients with Pulmonary Fibrosis. J Pulmon Resp Med 3: 145. doi:10.4172/2161-105X. 1000145 Copyright: © 2013 Afshar K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.